These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 16005196

  • 1. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets.
    van Veen B, Pajander J, Zuurman K, Lappalainen R, Poso A, Frijlink HW, Ketolainen J.
    Eur J Pharm Biopharm; 2005 Oct; 61(3):149-57. PubMed ID: 16005196
    [Abstract] [Full Text] [Related]

  • 2. Liquid boundary movements in cylindrical and convex hydrophobic matrix tablets: Effects on tablet cracking and drug release.
    Pajander J, van Veen B, Korhonen O, Lappalainen R, Ketolainen J.
    Eur J Pharm Biopharm; 2006 Oct; 64(2):167-72. PubMed ID: 16846722
    [Abstract] [Full Text] [Related]

  • 3. Modifying drug release and tablet properties of starch acetate tablets by dry powder agglomeration.
    Mäki R, Suihko E, Rost S, Heiskanen M, Murtomaa M, Lehto VP, Ketolainen J.
    J Pharm Sci; 2007 Feb; 96(2):438-47. PubMed ID: 17075868
    [Abstract] [Full Text] [Related]

  • 4. Drug release phenomena within a hydrophobic starch acetate matrix: FTIR mapping of tablets after in vitro dissolution testing.
    Pajander J, Soikkeli AM, Korhonen O, Forbes RT, Ketolainen J.
    J Pharm Sci; 2008 Aug; 97(8):3367-78. PubMed ID: 18085712
    [Abstract] [Full Text] [Related]

  • 5. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C.
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers.
    Korhonen O, Kanerva H, Vidgren M, Urtti A, Ketolainen J.
    J Control Release; 2004 Mar 24; 95(3):515-20. PubMed ID: 15023462
    [Abstract] [Full Text] [Related]

  • 7. Particle size distribution and evolution in tablet structure during and after compaction.
    Fichtner F, Rasmuson A, Alderborn G.
    Int J Pharm; 2005 Mar 23; 292(1-2):211-25. PubMed ID: 15725568
    [Abstract] [Full Text] [Related]

  • 8. Ultrasound transmission technique as a potential tool for physical evaluation of monolithic matrix tablets.
    Hakulinen MA, Pajander J, Leskinen J, Ketolainen J, van Veen B, Niinimäki K, Pirskanen K, Poso A, Lappalainen R.
    AAPS PharmSciTech; 2008 Mar 23; 9(1):267-73. PubMed ID: 18446491
    [Abstract] [Full Text] [Related]

  • 9. Effects of physical properties for starch acetate powders on tableting.
    Korhonen O, Pohja S, Peltonen S, Suihko E, Vidgren M, Paronen P, Ketolainen J.
    AAPS PharmSciTech; 2002 Mar 23; 3(4):E34. PubMed ID: 12916928
    [Abstract] [Full Text] [Related]

  • 10. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
    Hayashi T, Kanbe H, Okada M, Suzuki M, Ikeda Y, Onuki Y, Kaneko T, Sonobe T.
    Int J Pharm; 2005 Nov 04; 304(1-2):91-101. PubMed ID: 16154302
    [Abstract] [Full Text] [Related]

  • 11. Pore size distribution in tablets measured with a morphological sieve.
    Wu YS, van Vliet LJ, Frijlink HW, van der Voort Maarschalk K.
    Int J Pharm; 2007 Sep 05; 342(1-2):176-83. PubMed ID: 17580106
    [Abstract] [Full Text] [Related]

  • 12. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F, Bataille B, Cartilier L.
    Int J Pharm; 2008 May 22; 356(1-2):52-60. PubMed ID: 18280069
    [Abstract] [Full Text] [Related]

  • 13. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
    Bravo-Osuna I, Ferrero C, Jiménez-Castellanos MR.
    Eur J Pharm Biopharm; 2008 May 22; 69(1):285-93. PubMed ID: 17997292
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU, Okor RS.
    Pak J Pharm Sci; 2008 Jul 22; 21(3):230-6. PubMed ID: 18614417
    [Abstract] [Full Text] [Related]

  • 15. Dissolution characteristics of cylindrical particles and tablets.
    Fukunaka T, Yaegashi Y, Nunoko T, Ito R, Golman B, Shinohara K.
    Int J Pharm; 2006 Mar 09; 310(1-2):146-53. PubMed ID: 16414218
    [Abstract] [Full Text] [Related]

  • 16. Optimization of matrix tablets controlled drug release using Elman dynamic neural networks and decision trees.
    Petrović J, Ibrić S, Betz G, Đurić Z.
    Int J Pharm; 2012 May 30; 428(1-2):57-67. PubMed ID: 22402474
    [Abstract] [Full Text] [Related]

  • 17. Effect of formulation parameters and drug-polymer interactions on drug release from starch acetate matrix tablets.
    Pajander J, Korhonen O, Laamanen M, Ryynänen EL, Grimsey I, van Veen B, Ketolainen J.
    J Pharm Sci; 2009 Oct 30; 98(10):3676-90. PubMed ID: 19177516
    [Abstract] [Full Text] [Related]

  • 18. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR, Choi YW, Cui JH, Lee BJ.
    J Control Release; 2005 Nov 28; 108(2-3):351-61. PubMed ID: 16154656
    [Abstract] [Full Text] [Related]

  • 19. [Use of mercury porosimetry, assisted by nitrogen adsorption in the investigation of the pore structure of tablets].
    Szepes A, Kovács J, Szabóné Revész P.
    Acta Pharm Hung; 2006 Nov 28; 76(3):119-25. PubMed ID: 17094658
    [Abstract] [Full Text] [Related]

  • 20. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ, Windberg-Baarup A, Neri C, Byway PV, Booth SW, Fitzpatrick S.
    Int J Pharm; 2007 Jun 07; 337(1-2):246-53. PubMed ID: 17306477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.